October 19, 2010
![]() |
| Bankole Johnson |
Charlottesville, VA (RPRN) 10/19/10 — In my article in The Washington Post (http://www.washingtonpost.com/wp-dyn/content/article/2010/08/06/AR2010080602660.html), I provided empirical data that questioned the effectiveness of Alcoholics Anonymous (AA). Not surprisingly, the response of some who are vested in the advocacy of AA and other 12-step programs continues to be mostly anecdotal.
Fortunately, science has moved on from the days when a person can simply express an opinion without solid data. The recent article by Catherine Cosgrove of the Heritage Home Foundation (http://rushprnews.com/2010/10/06/do-12-step-drug-and-alcohol-rehabs-work) fails to acknowledge that more than 95% of my research funding comes from the National Institutes of Health.
Indeed, the last time my group did a study for Pharma was 2008, and I have not been the main investigator on a Pharma study for almost 5 years. Nevertheless, consultation by experts for industry is critical to the development of new medicines. I do not advocate for one medicine over another. My goal is to promulgate new knowledge about alcohol dependence that is commensurate with modern medicine to all, dispel myths, and show the way toward evidence-based treatment.
Yours sincerely,
Bankole A. Johnson, DSc, MD, PhD
Professor and Chairman, Department of Psychiatry and Neurobehavioral Sciences
University of Virginia
Bankole Johnson is the Alumni Professor and Chairman of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia. He also is a Professor of Neuroscience and a Professor of Medicine. Prof. Johnson graduated in Medicine from Glasgow University in 1982 and trained in Psychiatry at the Royal London and Maudsley and Bethlem Royal Hospitals. Additional to his medical degree, he trained in research at the Institute of Psychiatry (University of London) and conducted studies in neuropsychopharmacology for his doctoral thesis (degree from Glasgow University) on the Medical Research Council unit at Oxford University. More recently, in 2004, he earned his Doctor of Science degree in Medicine from Glasgow University—the highest degree that can be granted in science by a British university. Prof. Johnson's primary area of research expertise is the psychopharmacology of medications for treating addictions. He is a licensed physician and board-certified psychiatrist throughout Europe and in the U.S. He is the Principal Investigator on National Institutes of Health (NIH)-funded research studies utilizing neuroimaging, neuropharmacology, and molecular genetics techniques. His clinical expertise is in the fields of addiction, biological, and forensic psychiatry. Prof. Johnson's honors include service on numerous NIH review and other committees including special panels. He was the 2001 recipient of the Dan Anderson Research Award for his “distinguished contribution as a researcher who has advanced the scientific knowledge of addiction recovery”. He received the Distinguished Senior Scholar of Distinction Award in 2002 from the National Medical Association. He also was an inductee of the Texas Hall of Fame in 2003 for contributions to science, mathematics, and technology, and in 2006 he received the American Psychiatric Association’s (APA’s) Distinguished Psychiatrist Lecturer Award. In 2007, he was named as a Fellow in the Royal College of Psychiatrists, and in 2008 he was elected to the status of Distinguished Fellow of the APA. In 2009, he received the APA’s Solomon Carter Fuller Award, honoring an individual who has pioneered in an area that has benefited significantly the quality of life for Black people. Professor Johnson is on the editorial board of The American Journal of Psychiatry and reviews for over 30 journals in pharmacology, neuroscience, and the addictions. He has over 200 publications and has written or edited five books.
Filed Under: Article-byline, BREAKING NEWS, Health and Fitness, Lifestyle, PRESS RELEASE
RUSH PR NEWS newswire and press release services at rushprnews.com / Anne Howard annehowardpublicist.com
Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.
Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.
Rush PR News is not the contact for material published.